Soren Nielsen
Overview
Explore the profile of Soren Nielsen including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
415
Citations
11126
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kjaer M, Jorgensen A, Fjelstrup S, Dupont D, Bus C, Eriksen P, et al.
Biomolecules
. 2025 Feb;
15(2).
PMID: 40001558
Metabolic dysfunction-associated steatotic liver disease (MASLD) affects one-third of adults globally. Despite efforts to develop non-invasive diagnostic tools, liver biopsy remains the gold standard for diagnosing metabolic dysfunction-associated steatohepatitis (MASH)...
2.
Bennekou S, Allende A, Bearth A, Casacuberta J, Castle L, Coja T, et al.
EFSA J
. 2025 Jan;
23(1):e9121.
PMID: 39877303
The European Commission mandated EFSA to assess the toxicity of bromide, the existing maximum residue levels (MRLs), and possible transfer from feed into food of animal origin. The critical effects...
3.
Silver J, Trewin A, Loke S, Croft L, Ziemann M, Soria M, et al.
FASEB J
. 2024 Dec;
38(23):e70223.
PMID: 39625361
Mitochondria are central to cellular function, particularly in metabolically active tissues such as skeletal muscle. Nuclear-encoded RNAs typically localize within the nucleus and cytosol but a small population may also...
4.
Roge R, Truumees B, Nielsen S
Appl Immunohistochem Mol Morphol
. 2024 Nov;
32(10):453-455.
PMID: 39506287
Accurate diagnosis of cancer of unknown primary (CUP) poses a significant daily challenge for pathologists, necessitating reliable immunohistochemical (IHC) markers. SATB2 is a transcription factor primarily expressed in colorectal neoplasms....
5.
Heeboll S, Wegener G, Gronbaek H, Nielsen S
Am J Physiol Endocrinol Metab
. 2024 Sep;
327(6):E679-E685.
PMID: 39291967
Hepatic amino acid (AA) metabolism and glucagon secretion are linked in a feedback cycle in which circulating AAs stimulate glucagon secretion and alpha-cell proliferation, whereas glucagon stimulates hepatic AA catabolism....
6.
Norholm A, Kjaer I, Sondergaard E, Nellemann B, Nielsen S, Lebeck J
Int J Mol Sci
. 2024 Aug;
25(16).
PMID: 39201693
In adipose tissue, reduced expression of the glycerol channel aquaporin 7 (AQP7) has been associated with increased accumulation of triglyceride. The present study determines the relative protein abundances of lipolytic...
7.
Risikesan J, Heeboll S, Kumarathas I, Sondergaard E, Johansen R, Ringgaard S, et al.
J Lipid Res
. 2024 Jun;
65(7):100580.
PMID: 38901559
This study aimed to determine whether obese men with nonalcoholic fatty liver disease (NAFLD) display differences between those with simple steatosis versus steatohepatitis (NASH) in splanchnic and hepatic FFA and...
8.
Talamonti E, Davegardh J, Kalinovich A, van Beek S, Dehvari N, Halleskog C, et al.
Mol Metab
. 2024 May;
85:101931.
PMID: 38796310
Objective: Simultaneous activation of β2- and β3-adrenoceptors (ARs) improves whole-body metabolism via beneficial effects in skeletal muscle and brown adipose tissue (BAT). Nevertheless, high-efficacy agonists simultaneously targeting these receptors whilst...
9.
Richter M, Kemp I, Heeboll S, Winther-Sorensen M, Kjeldsen S, Jensen N, et al.
Metabolism
. 2024 Apr;
156:155915.
PMID: 38631460
Introduction: Glucagon receptor agonism is currently explored for the treatment of obesity and metabolic dysfunction-associated steatotic liver disease (MASLD). The metabolic effects of glucagon receptor agonism may in part be...
10.
Nielsen S, Jensen M
JCI Insight
. 2024 Apr;
9(9).
PMID: 38602778
Background: Upper-body obesity (UBO) results in insulin resistance with regards to free fatty acid (FFA) release; how this differs by fat depot and sex between adults with UBO and lean...